Skip to main content

Covaxin proven safe for children of 2-18 years age group in phase III study: Bharat Biotech

Covaxin proven safe for children of 2-18 years age group in phase III study: Bharat Biotech In a phase II/III research, Bharat Biotech International Ltd#39;s COVID-19 vaccine Covaxin was found to be safe, well-tolerated, and highly immunogenic in children and adolescents aged 2 to 18 years.

from Moneycontrol Business News https://ift.tt/buAiJ1p
Labels:

Comments

Post a Comment

Popular posts from this blog

German cabinet to hold secret session on Huawei#39;s role in 5G network: Report

Huawei faces international scrutiny over its ties with the Chinese government and suspicion that Beijing could use Huawei#39;s technology for spying, which the company denies. from Moneycontrol Business News http://bit.ly/2TyXzFb
Post a Comment
Read more

Infosys partners Avaloq to strengthen wealth management capabilities via digital platforms

Infosys will be a strategic implementation partner for Avaloq#39;s wealth management suite of solutions to help clients modernize and transform their legacy systems into cutting-edge digital advisory platforms, a statement said. from Moneycontrol Business News https://ift.tt/2THaSpn
Post a Comment
Read more